Inicio › Sobrepeso › Minnesota
Ensayos clínicos de Sobrepeso en Minnesota
11 estudios sobre Sobrepeso buscan participantes en Minnesota.
Ciudades en Minnesota
Texto oficial del estudio (inglés)
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- International Diabetes Center At Park Nicollet, Minneapolis
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351045A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- Headlands Research - Twin Cities, Maplewood
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07823608A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Headlands Research-Twin Cities, Maplewood
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07794579A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Headlands Research-Twin Cities, Maplewood
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07369011A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- University of Minnesota Masonic Children's Hospital, Minneapolis
- Mayo Clinic - PIN, Rochester
- Children's Minnesota Pediatric Endocrinology Clinic & McNeeley Diabetes Center, Saint Paul
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06672549A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Mankato
- ACCOMPLISH-2 Research Site, Minneapolis
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 18 a 79 · Todos los sexos · Actualizado el 20 oct 2026 · NCT07654374A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- University of Minnesota, Minneapolis
- Synexus Clinical Research US-MN, Richfield
ReclutandoFase 3
Edades de 8 a 18 · Todos los sexos · Actualizado el 30 sept 2026 · NCT07253285A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Mankato
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743450Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Mankato
- ACCOMPLISH-1 Research Site, Richfield
ReclutandoFase 3
Edades de 18 a 79 · Todos los sexos · Actualizado el 10 ago 2026 · NCT07654361A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
- Clinical Research Institute of Minnesota, Minneapolis
ReclutandoFase 4
Edades de 18 a 65 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07728383Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
- Minneapolis VA Health Care System, Minneapolis
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT06390345De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.